Ortho Regenerative Technologies Partners on Rotator Cuff Repair Trial

Ortho Regenerative Technologies (ORT) entered into a Material Transfer Agreement with an undisclosed medical device company for the exclusive use of their proprietary platelet-rich plasma (PRP) system in ORT's upcoming Phase I/II U.S. clinical trial of ORTHO-R rotator cuff tear repair.

The company will provide the PRP system disposable kits for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us